EirGen Pharma

Executive Summary

EirGen Pharma is a trusted Contract Development and Manufacturing Organization (CDMO) based in Waterford, Ireland, specializing in high-quality drug development, manufacturing, and packaging services. The company focuses on value-added generics, specialty medicines, and complex formulations, serving both human and companion animal health markets. Their expertise spans therapeutic areas such as oncology, hormonal therapies, endocrinology, and antivirals, making them a versatile partner for pharmaceutical companies seeking reliable and innovative solutions. Founded in 2008, EirGen has established itself as a key player in the CDMO space, leveraging advanced capabilities to support partners from early-stage development through commercial production. As a private entity, the company maintains flexibility and a customer-centric approach, enabling tailored solutions for complex drug delivery challenges. Looking ahead, EirGen Pharma is well-positioned to capitalize on growing demand for specialized CDMO services, particularly in complex formulations and generics. The company's strategic location in Ireland offers access to a skilled workforce and favorable regulatory environment. While specific financial details are not publicly disclosed, EirGen's reputation and track record suggest strong operational performance. Key catalysts include potential capacity expansions, new client partnerships, and regulatory approvals for complex generics. The company's commitment to quality and innovation positions it for sustained growth in the evolving pharmaceutical landscape.

Upcoming Catalysts (preview)

• 2026Expansion of Manufacturing Capacity in Waterford70% success
• TBDStrategic Partnership with a Major Pharma Company50% success
• 2027FDA Approval for a Complex Generic Product40% success